Xin et al. discovered that miR-329–3p could inhibit the proliferation and migration of HepG2 cells by suppressing the ubiquitin-specific peptidase 22 (USP22)-Wnt/β-catenin pathway, providing new insights into the etiology and potential treatment of HCC [45]. The gene discussed is USP22; the disease is hepatocellular carcinoma.